BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 36374840)

  • 1. Armamentarium in Drug Delivery for Colorectal Cancer.
    Ali A; Akhtar J; Ahmad U; Basheer AS; Jaiswal N; Jahan A
    Crit Rev Ther Drug Carrier Syst; 2022; 40(1):1-48. PubMed ID: 36374840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved Targeting of Cancers with Nanotherapeutics.
    Foster C; Watson A; Kaplinsky J; Kamaly N
    Methods Mol Biol; 2017; 1530():13-37. PubMed ID: 28150194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical considerations for targeting colorectal liver metastases with nanotechnology.
    Arshad U; Sutton PA; Ashford MB; Treacher KE; Liptrott NJ; Rannard SP; Goldring CE; Owen A
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1588. PubMed ID: 31566913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nano-Drug Delivery Systems Based on Different Targeting Mechanisms in the Targeted Therapy of Colorectal Cancer.
    Wang K; Shen R; Meng T; Hu F; Yuan H
    Molecules; 2022 May; 27(9):. PubMed ID: 35566331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives.
    Ali ES; Sharker SM; Islam MT; Khan IN; Shaw S; Rahman MA; Uddin SJ; Shill MC; Rehman S; Das N; Ahmad S; Shilpi JA; Tripathi S; Mishra SK; Mubarak MS
    Semin Cancer Biol; 2021 Feb; 69():52-68. PubMed ID: 32014609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theranostics Nanomedicine Applications for Colorectal Cancer and Metastasis: Recent Advances.
    Kasi PB; Mallela VR; Ambrozkiewicz F; Trailin A; Liška V; Hemminki K
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orally delivered targeted nanotherapeutics for the treatment of colorectal cancer.
    Zhang X; Song H; Canup BSB; Xiao B
    Expert Opin Drug Deliv; 2020 Jun; 17(6):781-790. PubMed ID: 32237921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diatom-Based Nanomedicine for Colorectal Cancer Treatment: New Approaches for Old Challenges.
    Tramontano C; De Stefano L; Rea I
    Mar Drugs; 2023 Apr; 21(5):. PubMed ID: 37233460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted nanoparticles for colorectal cancer.
    Cisterna BA; Kamaly N; Choi WI; Tavakkoli A; Farokhzad OC; Vilos C
    Nanomedicine (Lond); 2016 Sep; 11(18):2443-56. PubMed ID: 27529192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotechnology for colorectal cancer detection and treatment.
    Gogoi P; Kaur G; Singh NK
    World J Gastroenterol; 2022 Dec; 28(46):6497-6511. PubMed ID: 36569271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered nanoparticles for imaging and drug delivery in colorectal cancer.
    Pavitra E; Dariya B; Srivani G; Kang SM; Alam A; Sudhir PR; Kamal MA; Raju GSR; Han YK; Lakkakula BVKS; Nagaraju GP; Huh YS
    Semin Cancer Biol; 2021 Feb; 69():293-306. PubMed ID: 31260733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotechnology a Boon for Colorectal Cancer Treatment.
    Kriplani P; Guarve K
    Recent Pat Anticancer Drug Discov; 2023; 18(3):379-396. PubMed ID: 36221866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of the current scientific and regulatory status of nanomedicines and the challenges ahead.
    Hock SC; Ying YM; Wah CL
    PDA J Pharm Sci Technol; 2011; 65(2):177-95. PubMed ID: 21502077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotherapeutics: An insight into healthcare and multi-dimensional applications in medical sector of the modern world.
    Prasad M; Lambe UP; Brar B; Shah I; J M; Ranjan K; Rao R; Kumar S; Mahant S; Khurana SK; Iqbal HMN; Dhama K; Misri J; Prasad G
    Biomed Pharmacother; 2018 Jan; 97():1521-1537. PubMed ID: 29793315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of nanotechnology in reversing therapeutic resistance and controlling metastasis of colorectal cancer.
    Ren SN; Zhang ZY; Guo RJ; Wang DR; Chen FF; Chen XB; Fang XD
    World J Gastroenterol; 2023 Apr; 29(13):1911-1941. PubMed ID: 37155531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticle-Based Drugs: A Potential Armamentarium of Effective Anti-Cancer Therapies.
    Ahmad K; Rabbani G; Baig MH; Lim JH; Khan ME; Lee EJ; Ashraf GM; Choi I
    Curr Drug Metab; 2018; 19(10):839-846. PubMed ID: 28831911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functionalized FcRn-targeted nanosystems for oral drug delivery: A new approach to colorectal cancer treatment.
    Hameedat F; Pizarroso NA; Teixeira N; Pinto S; Sarmento B
    Eur J Pharm Sci; 2022 Sep; 176():106259. PubMed ID: 35842140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating Nanomedicines: Obstacles and Advancements.
    Swierczewska M; Crist RM; McNeil SE
    Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Nanoparticles: the Smart Way for the Treatment of Colorectal Cancer.
    Abdellatif AAH; Alshubrumi AS; Younis MA
    AAPS PharmSciTech; 2024 Jan; 25(1):23. PubMed ID: 38267656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent achievements in colorectal cancer diagnostic and therapy by the use of nanoparticles.
    Bartoş A; Bartoş D; Szabo B; Breazu C; Opincariu I; Mironiuc A; Iancu C
    Drug Metab Rev; 2016; 48(1):27-46. PubMed ID: 26828283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.